Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Fate Therapeutics Inc

Fate Therapeutics Inc (FATE)

Market is closed
News
13G Filing: Redmile Group and Fate Therapeutics Inc (FATE)

13G Filing: Redmile Group and Fate Therapeutics Inc (FATE)

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject...

Keep Reading →

December 20th, 2017 - Hedge Funds

Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

Fate Therapeutics Inc (NASDAQ:FATE) announced on Tuesday that it has entered into a definitive securities purchase agreement with certain institutional and other accredited investors.

Keep Reading →

November 22nd, 2016 - News Stock Analysis

Here's Why Traders Are Buzzing About These Five Stocks on Monday

Here's Why Traders Are Buzzing About These Five Stocks on Monday

Markets are off to a bullish start this week following a rise in oil prices and fading chances of a Brexit.

Keep Reading →

June 20th, 2016 - Market Movers News Tech

Hedge Funds Own Over 25% Of Fate Therapeutics Inc (FATE)

Hedge Funds Own Over 25% Of Fate Therapeutics Inc (FATE)

Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

November 21st, 2015 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)